Canton Strategic Holdings, Inc. (CNTN)
NASDAQ: CNTN · Real-Time Price · USD
2.440
-0.250 (-9.29%)
Sep 29, 2026, 11:23 AM EDT - Market open
Canton Strategic Holdings Market Cap
Canton Strategic Holdings has a market cap or net worth of $194.42 million as of September 29, 2026. Its market cap has increased by 990.57% in one year.
Market Cap
194.42M
Enterprise Value
157.18M
1-Year Change
990.57%
Ranking
Category
Stock Price
$2.44
ChartMarket Cap Chart
Since January 12, 2022, Canton Strategic Holdings's market cap has increased from $32.56M to $194.42M, an increase of 497.08%. That is a compound annual growth rate of 46.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 194.42M | 76.06% |
| Dec 31, 2025 | 110.43M | 2,713.07% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -86.20% |
| Jan 12, 2022 | 32.56M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Keros Therapeutics | 223.65M |
| Yarrow Bioscience | 223.30M |
| Compugen | 220.71M |
| Cartesian Therapeutics | 218.14M |
| Anavex Life Sciences | 217.84M |
| Protalix BioTherapeutics | 216.74M |
| Adagene | 214.86M |
| Eledon Pharmaceuticals | 214.74M |